Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Idec's humanized murine antibody enters phase II testing for SLE

April 12, 1999

Metabolically stable antiadhesion agents in development at Daikin

April 8, 1999

Phytopharm assumes increased responsibility for development of unique botanical product

April 7, 1999

Roche, deCode Genetics close in on osteoarthritis disease-causing gene

April 7, 1999

FDA approves ANDA for Oruvail

April 7, 1999

Prosorba Column now available in U.S. for treatment of rheumatoid arthritis

April 6, 1999

Bioniche enters supply agreement with Sanova for Suplasyn

April 6, 1999

Anika to initiate Orthovisc phase III clinical study in U.S. and Canada

April 5, 1999

New oral SLE therapy GL-701 awarded fast track designation

April 5, 1999

Cypress Bioscience closes partnership agreement with Fresenius

April 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...